S.Africa's Aspen and J&J in talks to produce COVID vaccine

Slideshow ( 3 images )

JOHANNESBURG (Reuters) – South Africa’s Aspen Pharmacare is in talks with Johnson & Johnson to produce the finished drug ingredient for manufacturing COVID-19 vaccine, according to a presentation uploaded on the company’s website on Thursday.

“The technical transfer agreement is under way with Johnson & Johnson to manufacture the FDF of their candidate COVID-19

vaccine Ad26.COV2-S,” the presentation said.

Source: Read Full Article